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Abstract. Multifrequency (0 to 0.3 mm−1 ), multiwavelength (633, 680, 720, 800, and 820 nm) spatial frequency
domain imaging (SFDI) of 5-aminolevulinic acid-induced protoporphyrin IX (PpIX) was used to recover absorption,
scattering, and fluorescence properties of glioblastoma multiforme spheroids in tissue-simulating phantoms and
in vivo in a mouse model. Three-dimensional tomographic reconstructions of the frequency-dependent remitted
light localized the depths of the spheroids within 500 μm, and the total amount of PpIX in the reconstructed images
was constant to within 30% when spheroid depth was varied. In vivo tumor-to-normal contrast was greater
than ∼1.5 in reduced scattering coefficient for all wavelengths and was ∼1.3 for the tissue concentration of deoxyhemoglobin (ctHb). The study demonstrates the feasibility of SFDI for providing enhanced image guidance during
surgical resection of brain tumors. © 2012 Society of Photo-Optical Instrumentation Engineers (SPIE). [DOI: 10.1117/1.JBO.17.5.056008]
Keywords: fluorescence; Fourier transforms; tomography.
Paper 12022 received Jan. 10, 2012; revised manuscript received Mar. 13, 2012; accepted for publication Mar. 21, 2012; published
online May 4, 2012.

1

Introduction

Fluorescence guidance in neurosurgery using 5-aminolevulinic
acid (ALA)-induced protoporphyrin IX (PpIX) is gaining popularity as a surgical adjunct to improve the extent of tumor resection.1–3 A randomized controlled phase III clinical trial by
Stummer and colleagues has shown greater extent of resection
and significantly higher 6-month progression-free survival in
patients with high-grade glioma (GBM) undergoing fluorescence guidance compared to conventional white-light-guided
surgery.4,5 Methods to quantify PpIX concentration in tissue
using a fiber-optic “point” probe and a spectrally constrained
model of light propagation have been shown to improve
tumor detection with enhanced accuracy (87%) compared to
the subjective visual fluorescence assessment (66%) used in
the Stummer studies.6,7 To better integrate this concept into
surgical guidance, this work explores the development of a
model-based wide-field fluorescence imaging method integrated
into a surgical microscope. Our goal is to develop quantitative,
depth-resolved imaging for fluorescence guidance during
neurosurgery.
To date, ALA-induced PpIX fluorescence guidance has been
based on violet/blue light to excite the Soret-band of the molecule (around λ ∼ 405 nm), which limits the penetration of the
probing signal to a few hundred microns at best, potentially
leaving residual tumor undetected when located below the
surgical surface. Fortunately, the excitation spectrum of PpIX
also possesses several longer wavelength excitation bands up
Address all correspondence to: Bruce J. Tromberg, University of California Irvine,
Beckman Laser Institute and Medical Clinic, Laser Microbeam and Medical
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to around λ ∼ 633 nm (Q-bands) and a broad emission spectrum
extending up to ∼720 nm that could be used to stimulate (and
detect) emissions from subsurface tumor. Despite the potential
benefits during surgery, efforts to detect fluorescence at depth
using model-based techniques are still in an early stage of development with promising preliminary results reported by
Kim et al.8 and Leblond et al.9
Spatial frequency domain imaging (SFDI) is a relatively new
method that uses red or near-infrared light together with CCD
detection to acquire wide-field images of tissue. Sinusoidal
patterns of varying spatial frequencies are projected onto tissue,
and the attenuation in the amplitude of the spatial patterns at
each CCD pixel is fitted to a model of light propagation in
order to form images of the tissue optical properties.10,11 SFDI
has recently been used to quantify PpIX concentrations in vivo
by accounting for tissue optical properties.12 Spatially modulated excitation also encodes the depth from which measured
optical signals originate because high spatial frequency patterns
penetrate less deeply into tissue than their lower frequency
counterparts because of multiple light scattering. This frequency
encoding enables depth information to be recovered through
three-dimensional (3-D) optical tomography.13
MostSFDI research has focused ongeneratingtwo-dimensional
(2-D) images by fitting the reflectance measure at each pixel
of a CCD array to a homogeneous model of light propagation.
With the approach, SFDI has been applied to quantitatively
image stroke,14 brain injury,15 cortical spreading depression,16
and layered structures in skin.17 SFDI techniques have also
been used to localize subsurface inhomogeneities,18 and to determine tissue optical absorption and scattering properties over a
0091-3286/2012/$25.00 © 2012 SPIE
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broad spectral range.19 Recently, several groups have reconstructed 3-D tomographic images using sinusoidal illumination
patterns,13,20,21 but these studies were limited to measuring the
optical properties of tissue simulating phantoms and did not
include in vivo or fluorescence measurements. While we have performed fluorescence SFDI, these preliminary studies did not
involve tomographic image reconstruction and were limited to
phantoms and/or skin.12,22 Likewise, while fluorescence optical
tomography with wide-field illumination has been reported for
phantom studies23,24 and whole-body mouse imaging,25 it has
not been reported either for spatial frequency domain illumination
or brain imaging.
In this study we implement, for the first time to our knowledge, fluorescence optical tomography using spatial frequency
domain illumination. We then demonstrate the ability of SFDI to
image GBM tumors based on endogenous contrast from hemoglobin and the tissue-scattering parameters as well as exogenous
contrast from ALA-induced PpIX fluorescence. We present
experiments in tissue simulating phantoms with embedded
GBM spheroids, and in an in vivo GBM mouse model. We
use 2-D SFDI to image endogenous optical properties and
observe that the reduced scattering coefficient (μs0 ) exhibits
significant contrast between normal brain and tumor. We then
successfully implement 3-D SFDI fluorescence tomography
to localize tumors through ALA-induced PpIX fluorescence.

2
2.1

Methods
Sample Preparation

The GBM spheroids used in the phantoms were grown from
grade IV GBM cells (ACBT) to tumor spheroids of ∼1 to
2 mm diameter according to established methods.26,27 Selected
spheroids were then positioned in tissue simulating phantoms
consisting of 85% water, 10% PBS, 5% of a fat emulsion
to simulate tissue scattering (Liposyn® 20%) resulting in a 1%
final concentration of fat particles, and gelatine (10 g∕100 mL).
Porcine erythrocytes were added (0.5% by volume) to simulate
optical absorption. For in vivo mouse imaging, GBM cells isolated from surgical specimens were injected into the brain of an
athymic (nude) mouse. The mouse began to show symptoms of
weight loss, decreased mobility, poor grooming, and increased
stress at ∼3 weeks. At this time it was injected ALA (150 mg∕
kg, i.p.) 3 h prior to imaging. At the time of imaging, the mouse
was anesthetized with i.p. ketamine/xylazine and secured in an
ear-bar frame.

2.2

Data Acquisition

A schematic of the instrument appears in Fig. 1. We imaged
reflectance and fluorescence by illuminating a liquid crystal
on silicon (LCOS) device (HEO 1080p, HOLOEYE Photonics
AG) with a 20-mW, ∼633-nm HeNe laser (1145AP, JDS Uniphase). The LCOS projected images on the sample consisted
of sinusoidal intensity patterns of the form

1
Si ðρÞ ¼ ½1 þ cosðk · ρ þ ϕi Þ;
2

(1)

where ρ represents a location on the sample surface, k is the spatial
projection wave number, ϕi is the phase of the spatial projection.
The spatial projection frequency f ¼ 2πjkj was varied from
f ¼ 0 mm−1 (no spatial modulation) to f ¼ 0.3 mm−1 in intervals
of f ¼ 0.05 mm−1 . At each spatial frequency, the intensity pattern
Journal of Biomedical Optics
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Fig. 1 Schematic of the SFDI instrument. Filters were removed when
imaging endogenous contrast.

was serially projected at three different phases (ϕi ¼ 0, 120, and
240 deg), and the remitted light resulting from each projection was
detected by a CCD array (Cascade 512B, Roper Scientific). The
average excitation intensity at the tissue surface for f ¼ 0 mm−1
was ∼1 mW∕cm2 . In fluorescence mode, the excitation light was
blocked at the detector with a 650-nm longpass filter
(peak transmission ¼ 90%, out-of-band OD > 5) followed by a
680-nm bandpass filter [full width at half maximum ðFWHMÞ ¼
20 nm, peak transmission ¼ 70%, out-of-band OD > 3]. To
image endogenous contrast, light from a quartz tungsten halogen
lamp (CF1000, Illumination Technologies) was filtered serially
at four wavelengths (680, 720, 800, and 820 nm) and coupled
to the LCOS via a 5-mm-core-diameter liquid light guide. Orthogonal linear polarizers were incorporated to eliminate glare from
specular reflections and were used in both the endogenous and
fluorescence scans. Data acquisition took ∼30 s (endogenous
contrast), and ∼100 s (fluorescence contrast). We expect to be
able to reduce these times by use of brighter sources and optimized
optics.

2.3

Data Analysis

The three images (I 1 , I 2 , I 3 ) at the different phases acquired for
each projected spatial frequency were combined according to
Ref. 13:

1
i
I tot ðρÞ ¼ ½2I 2 ðρÞ − I 1 ðρÞ − I 3 ðρÞ þ pﬃﬃﬃ ½I 1 ðρÞ − I 3 ðρÞ:
3
3
(2)
As can be seen by substituting the source term described by
Eq. (1) into Eq. (2), I tot ðρÞ represents the reflectance expected
from a source of the form Stot ðρÞ ∼ expðik · ρÞ. To produce 2-D
maps of the absorption coefficient, μa , and the reduced scattering coefficient, μs0 , at each wavelength, the amplitude of I tot ðρÞ
at each CCD pixel was fitted to a semi-infinite, homogeneous,
radiative transport model of light propagation aided by a rapid
look-up table approach.10 Tissue concentrations of oxyhemoglobin (ctHbO2 ) and deoxyhemoglobin (ctHb) were determined
through spectral fitting of the absorption values using the known
extinction coefficients for the two chromophores (assuming no
other significant absorbers were present).
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We reconstructed 3-D images of the concentration of PpIX
by adapting our previously published method for tomographic
imaging of absorption using SFDI.13 For continuous wave
illumination, the measured emission light at position ρd due
to illumination wavenumber k is related to the fluorophore
concentration by

Z
I tot ðk; qd Þ ¼

CðrÞ ¼

d3 rI ex ðk; rÞGem ðr; rd Þεðλex Þηðλex ; λem ÞCðrÞ;
(3)

where I ex ðk; rÞ is the photon density of excitation light in the
medium, εðλex Þ is the extinction coefficient of the fluorophore
at the excitation wavelength, ηðλex ; λem Þ is the fluorescence
quantum yield (<1% for PpIX), and CðrÞ is the fluorophore concentration. The Green’s function Gem ðr; rd Þ obeys the diffusion
equation at the emission wavelength

½−∇ · D∇ þ cμa Gðr; r 0 Þ ¼ δðr − r 0 Þ;

(4)

subject to the boundary condition

Gðr; r 0 Þ þ ln^ · ∇Gðr; r 0 Þ ¼ 0:

(5)

Here D ¼ 3∕cl is the diffusion coefficient, l is the extrapolation length, and n^ is the outward-pointing unit normal. For the
semi-infinite geometry, the Green’s function can be decomposed
into plane waves28 according to

Gðr; r 0 Þ ¼

1
ð2πÞ2

Z

d2 qgðq; z; z 0 Þ expfi½q · ðρ 0 − ρÞg; (6)

(12)

The inverse of Eq. (10) is used to calculate the fluorophore
distribution. It appears as

Z
I tot ðk; ρd Þ ¼

d2 ρ expðiqd · ρÞI tot ðk; ρd Þ:

Z
1
d2 q
expð−iq · ρÞ
εðλex Þηðλex ; λem Þ ð2πÞ2
X
κ ðkm ; qd ; zÞM −1
×
m;n ðqÞI tot ðkn ; qd Þ;

(13)

m;n

where

Z
M m;n ðqÞ ¼

∞

dzκðkm ; qd ; zÞκ ðkn ; qd ; zÞ:

(14)

0

In these formulas, the Fourier variable q is related to the projection wave number k and the Fourier variable conjugate to
the detector locations qd by q ¼ k þ qd. The subscripts ex and
em indicate whether the optical properties (μa and μs0 ) for the
respective variable refer to the excitation or emission wavelength (∼633 nm and 680 nm  20 nm, respectively). The
average optical properties at 633 nm (excitation) and 680 nm
(emission) obtained from the endogenous SFDI were used as
inputs in Eq. (5) for the tomographic fluorescence reconstructions. The inverses of the M matrices [see Eq. (14)] are needed
in Eq. (13). We take the inverse of each of these matrices
by solving its eigenvalue problem and setting all eigenvalues
below a threshold to zero. For this study the threshold
was kept constant at 10−4 . We solved for the fluorophore

where

Demodulate data using Eq. (2).

gðq; z; z 0 Þ ¼

0

l exp½−QðqÞjz − z j
;
D
QðqÞl þ 1

(7)
Fourier transform data using Eq. (12).

when either z or z 0 is located on the surface, and

QðqÞ ¼ ðcμa ∕D þ q2 Þ1∕2 :

For each spatial
frequency q in the
reconstructed image

(8)

Equations (6) and (7) allow us to represent the photon density
of the exitation light in the tissue appearing in Eq. (3) as

I ex ðk; rÞ ¼ gex ðk; 0; zÞ exp½ik · ρ:

Calculate matrix elements of M(q) using Eq. (14).

(9)
Find eigenvalues/functions of M(q).

Substituting Eqs. (6), (7), and (9) into Eq. (3) and taking a
Fourier transform with respect to the detector positions on the
surface result in

Z
I tot ðk; qd Þ ¼ εðλex Þηðλex ; λem Þ dzκðk; qd ; zÞ
Z
× d2 ρ exp½iq · ρCðrÞ;

Set small eigenvalues to zero and calculate M-1(q).

Calculate C(q,z) using summation in Eq. (13).

(10)

where

κðk; qd ; zÞ ¼

lex lem expf−½Qex ðkÞ þ Qem ðqd Þzg
;
Dex Dem ½Qex ðkÞlex þ 1½Qem ðqd Þlem þ 1
(11)

and
Journal of Biomedical Optics

Take inverse Fourier transform
of C(q,z) to get C(r).
Fig. 2 Flowchart of the three-dimensional fluorescence optical
tomography algorithm.
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Fig. 3 Fluorescence tomography reconstructions of PpIX concentrations for the GBM spheroid containing phantoms. (a) Cross-sectional image of the
subsurface spheroid taken after the phantom was cut in half. (b) Reconstructed image of the phantom with the spheroid at the surface. (c) As in (b) for the
subsurface spheroid. Each image in (b and c) corresponds to the reconstructed PpIX concentration at the depth indicated below the frame.

concentration over a 50 × 50 grid of points in the Fourier
domain with qmax ¼ 2.5π mm−1 and δq ¼ 0.1π mm−1 . Image
reconstruction required only ∼10 s on a single 2.80-GHz processor. A flowchart of the tomographic reconstruction algorithm
appears in Fig. 2.

3

Results

As an initial test of the ability to image relative PpIX concentrations in turbid media, two GBM spheroid phantoms were
evaluated. In the first phantom the spheroid was located with
its top surface level with the surface of the phantom, whereas
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Fig. 4 Two-dimensional images of the reduced scattering coefficient, oxyhemoglobin concentration, and deoxyhemoglobin concentration in the
mouse with (a) intact skull and (b) exposed brain. Plots of the scattering coefficient, μs0 , (c) and (d) concentrations of Hb and HbO2 for tumor
and normal regions are also shown. Error bars denote the standard deviation of pixel values in the region of interest.
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Table 1 Measured in vivo values in the mouse brain for tumor and normal tissue (Shown are the means and standard deviations of pixel values in the
tumor and normal regions of interest).
Skull intact
Tumor
μs0

(λ ¼ 680 nm)

(mm−1 )

Skull removed
Normal

Tumor

Normal

2.2  0.2

1.3  0.1

2.1  0.4

1.2  0.1

A

1.8  0.08

1.1  0.05

1.8  0.2

1.1  0.05

b

1.4  0.5

1.2  0.4

1.3  0.6

1.0  0.5

ctHb (μM)

43  5

33  3

47  6

36  5

ctHbO2 (μM)

52  9

52  6

60  8

60  9

(b)

(a)

0.8
0.6

0.5 mm

1.0 mm

1.5 mm

2.0 mm

2.5 mm

3.0 mm
1 mm

(c)

1
0.8
0.6

0.5 mm

1.0 mm

1.5 mm

2.0 mm

2.5 mm

3.0 mm

a.u.

Fig. 5 (a) Photograph of the skull in which the illumination pattern is visible. The dotted red line denotes the region of interest for the 3-D reconstructions. (b) Reconstructed images of PpIX concentration with the skull intact. (c) As in (b) with the brain surgically exposed. The corresponding
reconstructed image depth is indicated below each frame.

in the second phantom the spheroid was embedded such that its
top surface was located ∼1.5 mm beneath the phantom. After
imaging, the phantom containing the subsurface spheroid was
cut in half to confirm its location [Fig. 3(a)]. In the reconstructed
images, the maximum PpIX concentration of the superficial
spheroid [Fig. 3(b)] was reconstructed at a depth of 1 mm,
while the maximum for the subsurface spheroid [Fig. 3(c)]
was at a depth of 2 mm. Although both spheroids were approximately the same size (∼1.5 mm), the image of the superficial
spheroid had a lateral FWHM of 2.4 mm compared to 4.7 mm
for the deeper spheroid. The volume of contrast enhancement
in the reconstructed image with concentration greater than
50% of the maximum was also less for the superficial
(13.7 mm3 ) than for the deeper (66.8 mm3 ) spheroid. However,
the reconstructed maximum concentration of the superficial
spheroid was 3.6 times that of the deeper spheroid, such that
the estimated total amount of PpIX in the two images agreed
within 30%.
In the mouse images of the reduced scattering coefficient and
hemoglobin concentration through the intact skull [Fig. 4(a)] and
with the brain exposed [Fig. 4(b)], scattering contrast between
tumor and normal tissue (taken as an identically sized region
adjacent to the tumor) was >1.5 at all wavelengths [Fig. 4(c)].
Fitting scattering values to a power law of the form μs0 ¼
Aðλ∕λ0 Þ−b with λ0 ¼ 750 nm resulted in A and b values that
were greater for the tumor. As shown in Fig. 4(d), deoxyhemoglobin concentration, ctHb, was significantly higher in tumor than
in normal tissue, likely because of metabolic differences such
as angiogenesis and hypoxia. Oxyhemoglobin concentration
values, ctHbO2 , were similar for tumor and normal brain tissue.
These results are summarized in Table 1.
Journal of Biomedical Optics

Figure 5(a) shows a picture of the skull illuminated with spatially modulated 633-nm light (f ¼ 0.25 mm−1 ). The dotted red
line denotes the region of interest used in the fluorescence image
reconstruction. In the reconstructed images of PpIX concentration, the tumor appears slightly deeper with an intact skull
[Fig. 5(b)] than with the skull removed [Fig. 5(c)], with the maximum intensity occurring 1.5 mm and 1.0 mm below the surface,
respectively (actual skull thickness ∼ 0.5 mm). The presence of
the skull decreased the maximum concentration in the image
by 8%, increased the FWHM from 1.1 to 2.1 mm, and increased
the apparent tumor volume from 4.5 to 5.5 mm3 . Similar to
the phantom experiments, the effects of increased size and
decreased concentration offset each other such that the total
estimated amount of PpIX remained constant to within 10%.

4

Discussion

One feature common to all of the reconstructions in this study is
that deeper objects appear larger and with less contrast than
superficial ones. This is the result of a partial volume effect
that occurs because the interrogation volume of each measurement is larger than the features we are trying to reconstruct. As
a result, the reconstructed features have values somewhere
between those of their actual values and the background.
The effect is more pronounced for deeper structures because
the sensitivity functions are peaked near the surface and become
broader with depth. We have analyzed the partial volume effect
for SFDI in a previous publication where we showed that
tomographic image reconstruction ameliorated (but did not
eliminate) this effect in comparison to our 2-D imaging
methods.13
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We do not expect this partial volume effect to prevent the use
of SFDI tomography for neurosurgical resection of tumors.
Fluorescence-assisted surgical resection is guided by the qualitative presence or absence of fluorescent signal. Thus, the exact
peak concentration is of less importance than a measurement of
the fluorophore depth or the total amount of fluorophore present.
Knowledge of fluorophore depth could improve the efficiency of
surgical resection by allowing a surgeon to more confidently
dissect down to tumor below the cortical surface; then proceed
with more aggressive tumor resection while far from the deep
margin; and finally convert to slower, more meticulous removal
when the deep interface is near. The increase in size of the reconstructions with depth is expected to interfere with accurate estimates of deep tumor extent. However, as tumor can only be
removed from the surface of the operative field, the higher
volume estimates at depth are of less concern because they
are expected to decrease as tumor is removed and overall
depth is reduced.
It may be possible to obtain more accurate reconstructions by
using algorithms that allow for inhomogeneous tissue optical
properties. Such algorithms could be implemented with
finite-element or Monte Carlo methods to model light transport.
However, one of the main advantages of our reconstruction
method is its speed. This speed is necessary to make surgical applications feasible. The current reconstructions use ∼106 data points
and take only ∼10 s. In addition, they could be made faster by
parallel computing, by pre-calculating the eigenvalues/functions
of the M matrices, or by reconstructing over a reduced bandwidth.
We are able to attain this speed because we use homogeneous
tissue optical properties and a planar geometry to model light
transport. These assumptions make the Green’s function for
the diffusion equation translationally invariant and enable us to
write Eq. (3) in block diagonal form [see Eq. (10)] such that it
can be solved rapidly. Thus while we plan to explore the potential
benefits of modeling light transport through inhomogeneous
tissue, we expect that for applications requiring rapid feedback
(e.g., surgery), the algorithm proposed here will be better suited.

5

Conclusion

In summary, this proof-of-principle study demonstrates the ability of multiwavelength, multifrequency SFDI tomography to
localize small (∼mm) subsurface (∼2 to 3 mm deep) tumors
in tissue-simulating phantoms and in vivo using ALA-induced
PpIX fluorescence. These results suggest that SFDI may offer a
wide-field fluorescence imaging approach that accounts for
intrinsic tissue optical properties, characterizes subsurface
nests of tumor cells, and potentially provides contrast for
improved intraoperative neurosurgical guidance. Future studies
will provide more detailed insight into factors that limit SFDI
accuracy and performance, and explore the combination of
image guidance with probe-based methods.6,8,9
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